No evidence for links between autism, MMR and measles virus

W. Chen, S. Landau, P. Sham, Eric Fombonne

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Background. We examined whether, in the UK, there is an increased risk of autism (AD) following exposures, in early life, to: (1) wild measles; (2) live attenuated measles, alone or in combination as MMR; and (3) the alteration of the mumps strain within MMR. Method. We conducted time trend analyses of 2407 AD subjects born between 1959-93; and for comparison, 4640 Down's syndrome (DS) subjects born between 1966-93. Between 1968-86, we correlated variations in AD and DS births with wild measles incidence. Between 1959-93, we tested for abrupt changes in the long-term AD birth trend for the effects of introducing: (1) monovalent measles vaccines in 1968; (2) MMR immunization in 1988; and (3) the 'overnight switch' from mixed use of Urabe MMR to exclusive use of Jeryl-Lynn MMR in 1992. Incidence rate ratios (IRRs) were used as measures of association. Results. We found no significant association between AD births and exposure (prenatal and postnatal up to 18 months age) to population rates of measles infections, and no 'step-up' increase in AD births associated with the introduction of monovalent measles and MMR vaccines, and changing mumps strain. An unexpected reduction in AD births of 21% (95% CI 6.9-33.3%; P = 0.005) among the post-1987 birth cohorts was detected. Conclusion. No increased risk of AD following exposures to wild measles and vaccinations with monovalent measles, and Urabe or Jeryl-Lynn variants of MMR was detected. The precise meaning of the detected AD births reduction is unclear. Our study cannot exclude rare complications of MMR, given its correlational design.

Original languageEnglish (US)
Pages (from-to)543-553
Number of pages11
JournalPsychological Medicine
Volume34
Issue number3
DOIs
StatePublished - Apr 2004
Externally publishedYes

Fingerprint

Measles virus
Measles
Autistic Disorder
Parturition
Measles Vaccine
Mumps
Down Syndrome
Measles-Mumps-Rubella Vaccine
Term Birth
Incidence
Immunization
Vaccination
Infection
Population

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Psychology(all)
  • Clinical Psychology

Cite this

No evidence for links between autism, MMR and measles virus. / Chen, W.; Landau, S.; Sham, P.; Fombonne, Eric.

In: Psychological Medicine, Vol. 34, No. 3, 04.2004, p. 543-553.

Research output: Contribution to journalArticle

Chen, W. ; Landau, S. ; Sham, P. ; Fombonne, Eric. / No evidence for links between autism, MMR and measles virus. In: Psychological Medicine. 2004 ; Vol. 34, No. 3. pp. 543-553.
@article{375851e8ddd748e0acfc980f7f60e270,
title = "No evidence for links between autism, MMR and measles virus",
abstract = "Background. We examined whether, in the UK, there is an increased risk of autism (AD) following exposures, in early life, to: (1) wild measles; (2) live attenuated measles, alone or in combination as MMR; and (3) the alteration of the mumps strain within MMR. Method. We conducted time trend analyses of 2407 AD subjects born between 1959-93; and for comparison, 4640 Down's syndrome (DS) subjects born between 1966-93. Between 1968-86, we correlated variations in AD and DS births with wild measles incidence. Between 1959-93, we tested for abrupt changes in the long-term AD birth trend for the effects of introducing: (1) monovalent measles vaccines in 1968; (2) MMR immunization in 1988; and (3) the 'overnight switch' from mixed use of Urabe MMR to exclusive use of Jeryl-Lynn MMR in 1992. Incidence rate ratios (IRRs) were used as measures of association. Results. We found no significant association between AD births and exposure (prenatal and postnatal up to 18 months age) to population rates of measles infections, and no 'step-up' increase in AD births associated with the introduction of monovalent measles and MMR vaccines, and changing mumps strain. An unexpected reduction in AD births of 21{\%} (95{\%} CI 6.9-33.3{\%}; P = 0.005) among the post-1987 birth cohorts was detected. Conclusion. No increased risk of AD following exposures to wild measles and vaccinations with monovalent measles, and Urabe or Jeryl-Lynn variants of MMR was detected. The precise meaning of the detected AD births reduction is unclear. Our study cannot exclude rare complications of MMR, given its correlational design.",
author = "W. Chen and S. Landau and P. Sham and Eric Fombonne",
year = "2004",
month = "4",
doi = "10.1017/S0033291703001259",
language = "English (US)",
volume = "34",
pages = "543--553",
journal = "Psychological Medicine",
issn = "0033-2917",
publisher = "Cambridge University Press",
number = "3",

}

TY - JOUR

T1 - No evidence for links between autism, MMR and measles virus

AU - Chen, W.

AU - Landau, S.

AU - Sham, P.

AU - Fombonne, Eric

PY - 2004/4

Y1 - 2004/4

N2 - Background. We examined whether, in the UK, there is an increased risk of autism (AD) following exposures, in early life, to: (1) wild measles; (2) live attenuated measles, alone or in combination as MMR; and (3) the alteration of the mumps strain within MMR. Method. We conducted time trend analyses of 2407 AD subjects born between 1959-93; and for comparison, 4640 Down's syndrome (DS) subjects born between 1966-93. Between 1968-86, we correlated variations in AD and DS births with wild measles incidence. Between 1959-93, we tested for abrupt changes in the long-term AD birth trend for the effects of introducing: (1) monovalent measles vaccines in 1968; (2) MMR immunization in 1988; and (3) the 'overnight switch' from mixed use of Urabe MMR to exclusive use of Jeryl-Lynn MMR in 1992. Incidence rate ratios (IRRs) were used as measures of association. Results. We found no significant association between AD births and exposure (prenatal and postnatal up to 18 months age) to population rates of measles infections, and no 'step-up' increase in AD births associated with the introduction of monovalent measles and MMR vaccines, and changing mumps strain. An unexpected reduction in AD births of 21% (95% CI 6.9-33.3%; P = 0.005) among the post-1987 birth cohorts was detected. Conclusion. No increased risk of AD following exposures to wild measles and vaccinations with monovalent measles, and Urabe or Jeryl-Lynn variants of MMR was detected. The precise meaning of the detected AD births reduction is unclear. Our study cannot exclude rare complications of MMR, given its correlational design.

AB - Background. We examined whether, in the UK, there is an increased risk of autism (AD) following exposures, in early life, to: (1) wild measles; (2) live attenuated measles, alone or in combination as MMR; and (3) the alteration of the mumps strain within MMR. Method. We conducted time trend analyses of 2407 AD subjects born between 1959-93; and for comparison, 4640 Down's syndrome (DS) subjects born between 1966-93. Between 1968-86, we correlated variations in AD and DS births with wild measles incidence. Between 1959-93, we tested for abrupt changes in the long-term AD birth trend for the effects of introducing: (1) monovalent measles vaccines in 1968; (2) MMR immunization in 1988; and (3) the 'overnight switch' from mixed use of Urabe MMR to exclusive use of Jeryl-Lynn MMR in 1992. Incidence rate ratios (IRRs) were used as measures of association. Results. We found no significant association between AD births and exposure (prenatal and postnatal up to 18 months age) to population rates of measles infections, and no 'step-up' increase in AD births associated with the introduction of monovalent measles and MMR vaccines, and changing mumps strain. An unexpected reduction in AD births of 21% (95% CI 6.9-33.3%; P = 0.005) among the post-1987 birth cohorts was detected. Conclusion. No increased risk of AD following exposures to wild measles and vaccinations with monovalent measles, and Urabe or Jeryl-Lynn variants of MMR was detected. The precise meaning of the detected AD births reduction is unclear. Our study cannot exclude rare complications of MMR, given its correlational design.

UR - http://www.scopus.com/inward/record.url?scp=2342419981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342419981&partnerID=8YFLogxK

U2 - 10.1017/S0033291703001259

DO - 10.1017/S0033291703001259

M3 - Article

VL - 34

SP - 543

EP - 553

JO - Psychological Medicine

JF - Psychological Medicine

SN - 0033-2917

IS - 3

ER -